about
Sulfasalazine for ankylosing spondylitisMethotrexate for ankylosing spondylitisMethotrexate for ankylosing spondylitisSulfasalazine for ankylosing spondylitisLong term safety of etanercept in elderly subjects with rheumatic diseases.Risk for malignant lymphoma in ankylosing spondylitis: a nationwide Swedish case-control studySpondyloarthropathies in autoimmune diseases and vice versa.Biomechanical assessment of balance and posture in subjects with ankylosing spondylitis.Sulfasalazine Treatment Suppresses the Formation of HLA-B27 Heavy Chain Homodimer in Patients with Ankylosing Spondylitis.Dactylitis, a term for different digit diseases.Chlamydiae as etiologic agents in chronic undifferentiated spondylarthritis.Anti-TNF-alpha therapy with infliximab in spondyloarthritides.Emerging drugs for psoriatic arthritis.Chlamydia and chronic arthritis.Treating reactive arthritis: insights for the clinician.Clinical characteristics of importance to outcome in patients with axial spondyloarthritis: protocol for a prospective descriptive and exploratory cohort study.Differences in the prevalence of ankylosing spondylitis in primary and secondary care: only one-third of patients are managed in rheumatology.Reactive arthritis in India: a dermatologists' perspective.Which is the dominant factor for perception of rheumatic pain: meteorology or psychology?Biopsychosocial determinants of physical and mental fatigue in patients with spondyloarthropathy.Bone scintigraphy in axial seronegative spondyloarthritis patients: role in detection of subclinical peripheral arthritis and disease activity.
P2860
Q24187791-3C41B88B-C577-472A-B2D1-A62541E930C9Q24200564-B3B49A66-BB88-4031-84EF-EA046973AC12Q24244003-19AEFA51-A97B-4565-ADEE-C2CA2D14570AQ24244129-1DFE7F1E-D177-4CE0-AF0D-2F793F1F51C2Q35636875-A90B61FE-1DDF-474E-909C-DCD9C838B0B1Q35637884-5A910FDB-8447-42C3-90E0-3126ADDE799BQ35778847-6E8C622D-BE88-40E3-8872-0491BDB88379Q36455068-9CA3FCB6-FE42-42C1-A463-9975E64D6F7CQ36512479-67BE2B02-72D7-4649-9A14-2A959E80DF11Q36633685-D582E4CC-1C43-4AA9-A6C5-6CD9BB3958ECQ37376121-45A78E1E-C36B-4E12-8A73-A32E2A39CC98Q37729028-BEC05E4D-553D-4306-919E-698DA430A12CQ37763192-1FDF96C4-8061-4E1D-B5C1-4058D6C8C656Q37850326-34643EF3-52F2-4E92-A255-A366B8E7E3CDQ37853706-93BDDBFD-8970-403D-A274-AE88E925CA05Q38683408-C0A182A7-1DD9-4CF7-BD66-C13051767307Q39646861-470EC61A-731B-4333-8A53-3C19F65703DEQ44622202-49BA7D0E-513A-4EEE-AA6B-8122926EBE70Q44626811-B5367D45-6E04-4D48-9B01-934B42916EB1Q48374346-292BEE07-E4A0-4D5B-B4BC-B118B52FA599Q53814014-CB07F93C-959D-4E90-AEEB-912E30904C4B
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Seronegative spondyloarthritides.
@ast
Seronegative spondyloarthritides.
@en
type
label
Seronegative spondyloarthritides.
@ast
Seronegative spondyloarthritides.
@en
prefLabel
Seronegative spondyloarthritides.
@ast
Seronegative spondyloarthritides.
@en
P2093
P356
P1476
Seronegative spondyloarthritides.
@en
P2093
Astrid van Tubergen
Carlo Salvarani
Ignazio Olivieri
P304
P356
10.1053/BERH.2002.0263
P577
2002-12-01T00:00:00Z